Object. Longitudinal multiparametric MR imaging and histological studies were performed on simvastatin-or atorvastatin-treated rats to evaluate vascular repair mechanisms after experimental intracerebral hemorrhage (ICH).
S tatinS, 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) reductase inhibitors, provide neuroprotection with beneficial effects on the nervous and vascular systems by improving or restoring endothelial function, decreasing oxidative stress and vascular inflammation, and enhancing angiogenesis and neurogenesis. 10, 23 In previous studies, we found that atorvastatin and simvastatin enhanced functional outcome, and that atorvastatin enhanced angiogenesis and synaptogenesis after ischemic stroke.
3 Similar beneficial effects of simvastatin and atorvastatin have been suggested in relation to hemorrhagic stroke since ischemic stroke and hemorrhagic stroke have a number of common injury mechanisms. 19, 26 Contrast mechanisms in MR imaging are based on a wide variety of physical parameters, and MR imaging has been successfully applied to experimental ischemic stroke. 27 Magnetic resonance imaging has a high sensitivity for assessing the temporal evolution of ICH and may be useful in evaluating the impact of therapeutic interventions after experimental ICH in animal models 16, 20 and eventually in humans. To date, little is known about the longitudinal multiparametric MR imaging assessment of therapeutic intervention on the experimental model of ICH. In the present study, we used longitudinal multiparametric MR imaging and immunohistochemical analysis to assess the therapeutic effects after ICH in rats. We hypothesized that 1) statins reduce edema and vascular injury while promoting angiogenesis and synaptogenesis, and 2) multiparametric MR imaging can assess the Vascular recovery promoted by atorvastatin and simvastatin after experimental intracerebral hemorrhage: magnetic resonance imaging and histological study Laboratory temporal evolution of brain tissue injury and repair and the effects of therapeutic intervention after experimental ICH.
Methods

Experimental Model
All studies were approved by the Institutional Animal Care and Use Committee. Wistar rats (270-330 g, 22 rats) were anesthetized using isoflurane (3.5% induction, 1.0%-1.5% maintenance) in a 2:1 mixture of N 2 O/O 2 . Core temperature was maintained at 36°-37°C throughout all surgical and MR imaging procedures. Primary ICH was induced by direct infusion of autologous whole blood into the striatal region adjacent to the subventricular zone. 16, [20] [21] [22] For the acute time point study, the right femoral artery and vein were cannulated for monitoring of blood pressure and gases and for administration of the contrast agent used during MR imaging (Gd-DTPA: 0.2 mmol/kg body weight). For follow-up studies, the contrast agent was administered through a tail vein.
At 24 hours post-ICH, animals were randomly assigned to atorvastatin (2 mg/kg), simvastatin (2 mg/kg), or PBS (control) treatment groups (6 rats/group). The dosage was selected based on the previous study. 21 Treatment was given by oral gavage starting 24 hours post-ICH and continued daily for 7 days. Neurobehavioral testing consisted of a modified neurological severity score and cornering tests that were performed at 1, 4, 7, 14, 21, and 28 days post-ICH. 14, 16, [20] [21] [22] A group of sham animals (4 rats) was subjected to the same manipulations as rats with ICH (that is, the needle was inserted into the brain at the specified coordinates, left in place for 10 minutes, and then withdrawn), but no blood was injected. This group was also studied. Neurological function for sham animals was tested at 0, 1, 3, and 7 days postinjury. Sham animals were killed at 7 days for histological evaluation.
Magnetic Resonance Imaging
All MR imaging measurements were performed using a 7-T, 20-cm bore superconducting magnet (Magnex Scientific, Inc.) interfaced to a Bruker Avance console running Paravision 3.0.2 (Bruker Biospin MR imaging). 14, 16 After being anesthetized, the rats were placed in a holder equipped with a nose cone and ear bars. A 3-plane scout imaging sequence was used to iteratively adjust the position of the animal's head until the central slice was located at the level of the largest portion of the hematoma. A series of MR images including spin-lattice (T1) and spin-spin (T2) relaxation weighted imaging, diffusion weighted imaging, magnetization transfer weighted imaging, perfusion, BBB permeability, and susceptibility weighted imaging were acquired using a 32-mm field of view. The MR imaging examinations were performed pre-ICH (baseline), 1-3 hours after ICH onset, and at 1, 2, 7, 14, and 28 days post-ICH.
T1 sat Measurements
Estimates of T1 sat were acquired using an imaging variant of the T-one by multiple readout pulses (TOM-ROP) sequence. 2, 9 Measurements of T1 in the presence of off-resonance saturation of the bound proton signal (T1 sat ), a magnetization transfer-related parameter, were also generated using this method. This was done by inserting 2 continuous wave radiofrequency saturation pulses into the Look-Locker sequence: the first (4.5 seconds long) immediately before the inversion pulse and the second (40 msec long) after the signal acquisition. The offset frequency of saturation pulses was 8 kHz, and the rotational frequency of B 1 field was 0.5 kHz. Initially, the longitudinal magnetization was inverted using an 8-msec nonselective adiabatic hyperbolic secant pulse. One phase encode line of 32 small-tip angle gradient echo images (TE 7.0 msec) was acquired at 80-msec intervals after each inversion. With this sequence, a single slice T1 sat map was obtained in approximately 9 minutes (TR 8 seconds, 128 × 64 matrix, 2-mm slice thickness).
T2 Measurements
The T2 relaxation time was measured using a standard Carr-Purcell-Meiboom-Gill (CPMG) 2D Fourier transform multislice (that is, 13 slices each of 1-mm thickness) multiecho (6 echoes) MR imaging sequence. The TEs were 15, 30, 45, 60, 75 and 90 msec, and the TR was 5.0 seconds. Images were produced using a 128 × 64 matrix. The total time for the entire sequence was 5 minutes and 20 seconds.
Perfusion Measurements
The CBF estimates were acquired using an arterial spin labeling technique. 5 The arterial spin labeling method is based on the selective inversion of inflowing blood water protons at the level of the carotid arteries prior to 1 H MR imaging measurement in the brain. The inversion pulse was applied for 1 second at a B 1 amplitude of 0.3 kHz, and had a frequency offset of ± 6 kHz. It was followed by a spin echo sequence with a TR of 1060 msec and TE of 40 msec. Four averages of the image were acquired with the gradient polarities and the radiofrequency pulse frequency offsets reversed to remove any gradient asymmetries in the axial direction. The labeled slice was 1 mm thick and was located approximately 2 cm distal to the imaging slice. The image slice was 2 mm thick and was acquired using a 64 × 64 matrix. The total time for the entire series was 18 minutes.
Magnetic Resonance Imaging Data Processing and Analysis
All MR imaging data were transferred to a UNIX system for image processing and analysis. All MR images were reconstructed using a 128 × 128 matrix. The T2 maps were produced on a pixel-by-pixel basis using a linear least-square fit. The 28-day post-ICH T2 maps were coregistered to corresponding histology sections using Eigentool software. For each animal, the T2 map with the largest area of acute hematoma was chosen for the analysis of temporal evolution. The T2 maps at later points were coregistered to the acute time point T2 map. Regions of interest representing the hematoma core and edematous border were identified by windowing T2 values. Abnormal T2 values were identified as > ± 1 standard deviation. At the acute time point, T2 values were low in the core and high in the rim. At time points ≥ 24 hours post-ICH, however, these trends reversed with T2 values in the core becoming elevated and T2 values in the rim area decreasing below normal levels. All other MR imaging parameter maps were coregistered to the T2 maps. The MR imaging parameters were measured in these selected regions of interest and the corresponding contralateral regions.
Immunohistochemical Analysis
At the 4th week after MR imaging examinations, the animals were anesthetized with ketamine (44 mg/kg) and xylazine (13 mg/kg) administered intraperitoneally. They were then perfused transcardially with PBS, followed by 4% paraformaldehyde in PBS. The intact brain was immediately removed and immersed in fixative overnight. For the purpose of mitotic labeling of newly synthesized DNA, all rats received daily injections of BrdU (100 mg/kg) administered intraperitoneally (Sigma) starting 24 hours after ICH and then subsequently for the next 13 days. Six coronal slides from every 40th 6-µm-thick slide of the block (bregma 0.1 mm to −0.86 mm) in each rat were specifically selected for immunohistochemical staining for vWF monoclonal antibody (dilution 1:100, Dako) and BrdU monoclonal antibody (dilution 1:200, Dako) or synaptophysin monoclonal antibody, clone SY 38 (dilution 1:40, Boehringer Mannheim Biochemica).
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For measurement of vascular perimeters and synaptophysin immunoreactivity, 6 immunostained coronal sections and 8 consecutive fields of view from the ipsilateral striatum, which is adjacent to the hematoma in each section, were digitized using a magnification of 20 (Olympus BX40, Olympus Optical Co.) on a 3-color charge-coupled device video camera (model DXC-970MD, Sony Corp.) interfaced with the MCID computer imaging analysis system (Imaging Research, Inc.). The numbers of vessels and their perimeters were counted and the total vascular perimeters were calculated throughout each field of view. The percentage of positive area for synaptophysin was measured.
Statistical Analysis
Statistical analyses of the ipsilateral/contralateral values of MR parameters at various times post-ICH, between statin-treated and control groups were evaluated using mixed-models ANOVA techniques, which take into account the possible correlation among the repeated time points within the same animal. Immunohistological measures of synaptophysin and vWF expression between groups were compared using ANOVA. Data are reported as the mean ± SEM. Statistical significance was inferred at p ≤ 0.05. All measurements were performed by observers blinded to individual treatments.
Results
All animals with ICH showed similar deficits prior to randomization at 1 day post-ICH. Both statin-treated groups showed significant neurobehavioral improvement from 2 weeks post-ICH onward compared with controls.
14 Figure 1 shows an example of quantitative CBF, T2, and T1 sat maps from a representative atorvastatin-treated rat at various times before and after experimental ICH. In the sham group, there was no apparent change in brain tissue staining (that is, no hemorrhage or tissue loss) and no effect on behavioral function 1 week after surgery. Based on these results and previous studies, 30 we did not expect to see any measurable changes in the sham group; therefore, they were not examined by MR imaging or additional immunohistochemical analysis.
Statin Modulates BBB Permeability
In a previous study, we showed the magnetization transfer-related parameter T1 sat was responsive to changes in BBB permeability in ICH-affected brain tissue.
14 In the current study, the ipsilateral/contralateral T1 sat ratios decreased acutely in the core region immediately post-ICH and then became elevated at later times, whereas only minor T1 sat changes were noted in the rim (Fig. 2) . Statin intervention significantly decreased T1 sat values in the rim at 4 weeks in both statin treatment groups compared with the control group (p = 0.02 for the atorvastatin-treated group, p = 0.003 for the simvastatin-treated group).
Statin Decreases Edema
Elevated ipsilateral/contralateral T2 ratios in the hematoma and surrounding tissue correspond to increased water content or edema relative to the corresponding contralateral regions (Fig. 3) . The ipsilateral/contralateral T2 ratio changes were distinct between the core and rim areas after ICH. The T2 values in the core declined acutely and then became elevated at later times relative to corresponding contralateral regions, whereas T2 in the rim was elevated acutely and then decreased at later times relative to contralateral regions. After both statin therapies, the T2 ratios significantly decreased at 4 weeks in the core (p = 0.029 for atorvastatin, p = 0.027 for simvastatin) and rim (p = 0.017 for atorvastatin, p = 0.047 for simvastatin) compared with the control group.
Statin Increases CBF
Representative examples of quantitative CBF at various times and ipsilateral/contralateral CBF ratios for core and adjacent rim areas plotted as a function of time are shown in the top row of Figs. 1 and 4 , respectively. The CBF values in both the core and rim regions decreased relative to contralateral regions at all time points. Furthermore, CBF values in the core were lower than those in the rim area at all time points. Treatment with statin significantly increased CBF at 4 weeks around the hematoma compared with the control group (p = 0.0015 for atorvastatin, p = 0.043 for simvastatin), but did not differ significantly between statin treatments (p = 0.12).
Statin Induces Angiogenesis
After ICH, the microvessels in the boundary zone around the hemorrhage clot had very narrow clefts be-tween the vessels and the parenchyma and few enlarged, thin-walled or intussusception vessels were found. To determine if statin promoted the proliferation of microvessels in this area, the perimeter of vessels 4 weeks after ICH was determined using vWF immunostaining (Fig.  5) . Results indicated that the total perimeters of vWFpositive microvessels in set areas in the boundary zone of the statin-treated groups were significantly higher than that of the PBS group (p = 0.016 for atorvastatin, p = 0.004 for simvastatin). The simvastatin-treated group, however, showed no significant difference from the atorvastatin group (p = 0.554).
Statin Increases Synaptophysin Expression
The functional benefits derived from statin treatment of ICH from our previous results suggest an effect on synaptogenesis.
14 Synaptophysin, a synaptic vesicleassociated protein, is a marker for presynaptic plasticity and synaptogenesis. Four weeks after ICH, the density of synaptophysin signals in the boundary zone was less than in the intact striatum (Fig. 6 ). After treatment with statin, the density significantly increased in this area compared with the control rats. Significantly increased synaptophysin expression was observed in the statin-treated rats compared with control (p = 0.048 for atorvastatin, p = 0.007 for simvastatin). No significant difference was detected between the simvastatin-and atorvastatin-treated groups (p = 0.384). These data suggest that statin treatment in ICH may protect synapses or induce synaptogenesis in the boundary zone.
Discussion
Approximately 80% of primary ICHs originate from the spontaneous rupture of small vessels that are impaired by long-standing or uncontrolled arterial hypertension. 1 The initial local intracranial bleeding imposing physical and chemical stress causes a secondary and more destructive influence on brain vessels, including brain edema formation, impairing CBF, and increasing BBB Fig. 1 . Examples of quantitative CBF, T2, and T1 sat maps at various times before and after experimental ICH in representative atorvastatin-treated rats. The CBF maps (upper) indicate normal flow before ICH that decreases severely after ICH, particularly in the central core region. The T2 maps (center) show a dark central core region (low T2) and adjacent surrounding bright rim (high T2) acutely that reverses in intensity at 24 hours and beyond. Increased BBB permeability was noted in core and rim areas at 24 hours that increased further in the core while stabilizing or decreasing slightly in the rim in the T1 sat maps (lower). permeability. 15 These changes in the pathophysiology of cerebral damage after ICH can be tracked and assessed by the quantitative MR imaging in animal models.
14 Perihematomal injury and the subsequent inflammatory cascades initiated by the coagulation products and the toxic blood breakdown products lead to disruption of the BBB. 28 The increasing BBB permeability contributes to brain edema formation and facilitates inflammatory cytokine migration, resulting in sustained neurological deterioration. Although known as potent cholesterol-lowering drugs, the statins can produce a number of pleiotropic effects, including inhibition of a number of isoprenoid intermediates. 15, 25 Ifergan and colleagues have shown that statins can stabilize the BBB integrity by interfering with isoprenylation events. 11 The current study also demonstrated that statins attenuate the change in BBB permeability after ICH.
In addition to BBB disruption, blood coagulation and breakdown products can induce inflammation and osmotic shifts in tissue water content, which are responsible for edema development after ICH. A number of studies have shown that increased brain edema around the hematoma is associated with poor outcome in patients. 29 In this study, we have shown that brain edema developed and peaked around the hematoma within hours after onset, while in the core area, the edema progressed further up until 4 weeks. After statin therapy, brain edema decreased to about 10%-20% in both the rim and core. Using collagenase-induced ICH animals, Jung et al. 13 observed that the statin decreased infiltration of leukocytes and microglia and increased endothelial nitric oxide synthase expression. Therefore, statins may protect the brain vessels from inflammation and improve endothelial function by enhancing nitric oxide bioavailability.
Statins have been shown to enhance CBF in clinical and experimental ischemic stroke.
6,7 Enhancement of CBF can attenuate the ischemic neuronal injury and improve neurological recovery. Although it is still controversial whether secondary cerebral ischemia occurs in the brain after ICH, several studies have reported that CBF and the cerebral metabolic rate of oxygen were reduced in the perihematoma area. 1, 16, 28 In our study, CBF was found to be low around the hematoma soon after ICH, compared with the contralateral side. Statin intervention tends to increase CBF around the hematoma starting at 1 week. After 4 weeks, CBF in the ipsilateral hemisphere of the treatment group recovered to as much as 80% of the contralateral levels (significantly different from the control group).
Statistically significant improvement of CBF was detected in the 4th week but not at earlier time points, suggesting that the neuroprotective effect of statins may be insufficient to contribute to the improvement of pathophysiological change in the early stage after ICH. Angiogenesis along the border zone, detected 4 weeks after ICH, may be a pathway for enhanced CBF at the later stage of ICH. Although significant changes in CBF were seen in the statin-treated animals compared with controls, it is doubtful that the magnitude of the CBF improvement seen could be attributed entirely to angiogenesis. It is probably more likely that at least some of the beneficial effects of statin treatment in ICH are due to protection of existing blood vessels in the rim area from further ICH-induced injury or possibly a combination of vascular protection and angiogenesis. There is increasing evidence that statins increase angiogenesis by improving endothelial function via an increase in endothelium-derived nitric oxide. 8, 15 A direct link has been revealed between statins and the serine/threonine protein kinase Akt that regulates multiple angiogenic processes in endothelial cells. 15 Extensive synaptic reorganization and neurological functional recovery have been attributed to the reduction of neurological deficits after stroke and brain trauma. 3, 17 It appears that synaptophysin may play a critical role in regulating synapse formation. 24 In a study using an animal model of stroke, treatment with low-dose atorvasta- Fig. 3 . Plot of T2 ratios (ipsilateral/contralateral) as a function of time after ICH onset for regions in the central core and surrounding rim of the lesion. In the core, T2 declined significantly at the acute stage and then became significantly elevated at later times relative to the corresponding contralateral region. Conversely, T2 ratios in the rim were elevated acutely and then decreased at later times. Simvastatin/atorvastatin therapies significantly lowered T2 values in the core and rim at 4 weeks after ICH. *p < 0.05. tin initiated 24 hours after injury significantly promoted synaptophysin expression in the ischemic boundary and improved functional outcome. 3 In our current study, synaptophysin density significantly increased in the boundary zone around the hematoma after statin treatment. The simvastatin and atorvastatin groups had significant neurological improvement from 2 weeks post-ICH onward.
14 Therefore, enhanced synaptic formation by statins may contribute to functional outcome. The vascular recovery may be important in promoting synapse formation, because angiogenesis has been linked to improved neuronal recovery. 4 However, it is undetermined whether appropriate synaptic connections can form and integrate into the adult brain.
Statins penetrate the BBB with different efficiency, depending on their lipophilicity. 12 Despite simvastatin having a greater permeability across the BBB than atorvastatin, 31 the present data indicate that at a dose of 2 mg/ kg/day, simvastatin and atorvastatin have similar protective and restorative effects on ICH.
Several limitations should be considered in the present study. Rodent ICH models have limitations when comparing outcome measures with the human ICH condition. The resolution of the clot and functional improvement is faster in the collagenase and the injection experimental models of ICH, the latter method being used in this experiment. Extrapolation to human recovery with statin use cannot be made. Other authors have noted that there are limitations of MR imaging measurements early after ICH in the rodent models; the mass effect of the clot makes discernment of T2 significance difficult. 18 This may be a reason why we could only find significant changes in MR imaging parameters at the latest time point after ICH.
Probably the most important shortcoming of the present study is the small number of study animals, which somewhat precludes an extensive analysis of the various correlative comparisons that could be made between MR imaging, neurobehavioral, and histological data. While it would be interesting and desirable to test for such relationships, the small sample sizes available in the present study lack the statistical power that would be needed to perform such an analysis. Another problem occurs when trying to compare MR imaging data with histological and immunohistochemical data due to differences in slice thickness and distortion of the sections caused by tissue shrinkage that occurs during histological preparation. We allow roughly 25% to account for shrinkage in the slice direction, but the in-plane shrinkage of the sections can be nonlinear and more difficult to correct for.
Conclusions
Simvastatin and atorvastatin have a beneficial effect after experimental ICH due to a vascular restorative mechanism demonstrated by histochemical and MR imaging evidence of angiogenesis and improved vascular functioning in the ICH border zone. The ICH region also shows correlative evidence of neuronal recovery with increased synaptophysin expression. 
